MAPK3 and lung cancer: Activation of cell membrane nAChRs via α7 and β2 subunits is associated with increased expression of cyclin D1 and phosphorylation of ERK1/2, inhibition of mPTP opening and resistance to H2O2-induced apoptosis in oral and lung cancers [15].